[BioNLP] [Oae-devel] ICBO 2012 workshop - Vaccine and Drug Ontology in the Study of Mechanism and Effect (VDOSME-2012)

Dingcheng Li lixxx345 at umn.edu
Mon Apr 16 23:54:45 EDT 2012

Study of Mechanism and Effect (VDOSME-2012)

DEADLINE EXTENDED to April 30th (Firm):
ICBO 2012 workshop - Vaccine and Drug Ontology in the Study of Mechanism and
Effect (VDOSME-2012)
July 21st 2012, Graz, Austria


Vaccines and drugs have contributed to dramatic improvements in public
health worldwide. Over the last decade, there have been efforts in
biomedical ontology that represent various areas associated with vaccines
and drugs and which join existing health and clinical terminology systems
(e.g., SNOMED, RxNorm, NDF-RT, and MedDRA) in their application to research
and clinical data.

The "Vaccine and Drug Ontology in the Study of Mechanism and Effect" (VDOSME
2012) workshop will provide a platform for discussing problems and solutions
in the development and application of biomedical ontologies to representing
and analyzing vaccines/drugs, vaccine/drug administrations,
vaccine/drug-induced immune responses, and similar topics. The workshop will

Ontology Coverage: Ontologies of vaccines, of drugs, and of studies thereof.
Scope of Interest: Representations and analyses of vaccine and drug
formation and preparation, administration, mechanisms, and effects based on
such ontologies.

Examples of biomedical subject matter in the scope of this workshop:
vaccine/drug components (e.g., vaccine antigens, drug active ingredients,
and adjuvants), administration details (e.g., dosage, administration route,
and frequency), gene immune responses and pathways, drug-drug or drug-food
interactions. We will also focus on computational methods used to study
these, for example, literature mining of vaccine/drug-gene interaction
networks, meta-analysis of host immune responses, and time event analysis of
vaccine/drug effects.

All workshop attendees will be expected, at the workshop, to present either
descriptions of their work or to articulate a position. In addition a number
of participants will be selected to lead interactive sessions on focused

*** Submission Guidelines ***
Full papers must describe novel ontology-related research, not previously
been published and not submitted to other conferences. Short papers describe
research results which are more preliminary or communicate brief position
statements. We also invite full length application-oriented papers, to
showcase the development of novel and successful applications utilizing
ontologies and knowledge-based technologies.

The maximum allowed page lengths of contributions are as follows.

Full paper submission: 5 pages, due Apr 30 (Firm), 2012
Short paper submission: 3 pages, due Apr 30 (Firm), 2012
Statement of interest: 1-2 pages, due Apr 30 (Firm), 2012

*** Journal Publication ***
All full-length papers accepted in this workshop will be invited to extend
the workshop papers and be included in a special issue in the Joural of
Biomedical Semantics. We believe that the eventual inclusion of accepted
full-length publication in the special issue will stimulate more submissions
of high quality manuscripts.

*** Contact ***
If you have any question or which to enquire about the workshop, please
contact us at organizers-vdosme2012 at googlegroups.com.

*** Chairs ***
Yongqun ³Oliver² He, University of Michigan
Luca Toldo, Merck KGaA
Gully Burns, Information Sciences Institute
Cui Tao, Mayo Clinic
Darrell R. Abernethy, U.S. Food and Drug Administration (FDA)

*** Program committee (PC) Members ***
Richard Boyce, University of Pittsburgh
Lindsay Cowell, University of Texas Southwestern Medical Center
Dingcheng Li, Mayo Clinic
Asiyah Yu Lin, University of Michigan
Bjoen Peters, La Jolla Institute for Allergy and Immunology
Sira Sarntivijai, University of Michigan/US FDA
Nigam Shah, Stanford University
Sunghwan Sohn, Mayo Clinic
Larisa Soldatova, Aberystwyth University
Stephen Wu, Mayo Clinic
Qian Zhu, Mayo Clinic

More information is available at:

A related workshop in ICBO 2012:
Workshop Name: Methods for adverse events representation Ontology and
Information Model
URL: http://kr-med.org/icbofois2012/adverse_events/


Yongqun "Oliver" He, DVM, PhD
Associate Professor
Unit for Laboratory Animal Medicine
Department of Microbiology and Immunology
and Center for Computational Medicine and Bioinformatics
University of Michigan Medical School
Ann Arbor, MI 48109
Email: yongqunh at med.umich.edu
Tel: 734-615-8231 (O)

Electronic Mail is not secure, may not be read every day, and should not be
used for urgent or sensitive issues

For Developers, A Lot Can Happen In A Second.
Boundary is the first to Know...and Tell You.
Monitor Your Applications in Ultra-Fine Resolution. Try it FREE!
Oae-devel mailing list
Oae-devel at lists.sourceforge.net

------ End of Forwarded Message

------ End of Forwarded Message
-------------- next part --------------
HTML attachment scrubbed and removed

More information about the BioNLP mailing list